tiprankstipranks
Trending News
More News >
Plus Therapeutics Reports 2024 Financial Results and Progress
PremiumCompany AnnouncementsPlus Therapeutics Reports 2024 Financial Results and Progress
15d ago
Plus Therapeutics announces FDA conditionally accepted name REYOBIQ
Premium
The Fly
Plus Therapeutics announces FDA conditionally accepted name REYOBIQ
23d ago
Plus Therapeutics initiated with a Buy at D. Boral Capital
Premium
The Fly
Plus Therapeutics initiated with a Buy at D. Boral Capital
26d ago
Plus Therapeutics sees $15M in gross proceeds from private placement
PremiumThe FlyPlus Therapeutics sees $15M in gross proceeds from private placement
1M ago
Plus Therapeutics granted orphan designation for lung cancer treatment
Premium
The Fly
Plus Therapeutics granted orphan designation for lung cancer treatment
1M ago
Plus Therapeutics advances Rhenium Obisbemeda
Premium
The Fly
Plus Therapeutics advances Rhenium Obisbemeda
1M ago
Plus Therapeutics (PSTV) Q4 Earnings Cheat Sheet
PremiumPre-EarningsPlus Therapeutics (PSTV) Q4 Earnings Cheat Sheet
2M ago
Plus Therapeutics presented data on ReSPECT-LM Phase 1 trial
Premium
The Fly
Plus Therapeutics presented data on ReSPECT-LM Phase 1 trial
4M ago
Plus Therapeutics expands strategic agreement with Telix IsoTherapeutics
Premium
The Fly
Plus Therapeutics expands strategic agreement with Telix IsoTherapeutics
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100